IL6 and psoriasis: Psoriasis is a quintessential immune-mediated inflammatory disorder, marked by heightened levels of proinflammatory markers and cytokines, including, but not limited to, tumor necrosis factor (TNF)-α, IL-6, IL-17, IL-22, and IL-238,9.